Related Articles
DCLK1 and its interaction partners: An effective therapeutic target for colorectal cancer (Review)
MicroRNA‑223‑5p suppresses the progression of nasopharyngeal carcinoma by targeting DCLK1
Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells
Adrenic acid: A promising biomarker and therapeutic target (Review)
LncRNAs and cancer (Review)